Convergence Pharmaceuticals Ltd
Convergence Pharmaceuticals is focused on the development of novel analgesics with potentially commercially attractive efficacy, responder-rate and side effect profiles. The company was formed in 2010 as the first independent spin-out from GSK, has a pipeline of differentiated clinical-stage compounds targeting the points of convergence in chronic pain signaling through modulation of specific ion-channels and other mechanisms. In 2015 it was acquired by Biogen Inc as a wholly owned subsidiary Email: info@convergenecepharma.com
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
11 to 50
headcount range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Convergence Pharmaceuticals Ltd
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Convergence Pharmaceuticals Ltd
1 distinct titles indexed · top 1 shown.
- 1vp head of biology
Sign up to unlock all 2 contacts at Convergence Pharmaceuticals Ltd
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Convergence Pharmaceuticals Ltd
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.